Compass Pathways says a single dose of its synthetic psilocybin significantly reduced depression symptoms in patients who haven’t responded to standard treatments, marking a key milestone in what could become the first FDA-approved psychedelic therapy for treatment-resistant depression. The company announced that its lead candidate, COMP360, met the primary endpoint in its Phase 3 COMP005 …
Category: News
Jones Soda Sells Mary Jones Cannabis Beverage Line for $3 Million to Privately Held Company
Jones Soda Co., a craft beverage company known for its premium sodas and unique consumer engagement, today announced that it has sold its cannabis beverage business, including all related cannabis-specific assets under the Mary Jones™ brand, to MJ Reg Disrupters LLC (“MJ Reg”), a privately held company. The transaction is part of Jones’ previously announced …
Texas Hemp Business Council Praises Governor’s Decision to Veto Hemp THC Ban
The Texas Hemp Business Council, an industry organization dedicated to promoting the hemp-based cannabinoid industry in Texas, sent out a press release this morning praising Governor Abbott’s decision to veto Senate Bill 3. “Governor Greg Abbott’s veto of SB 3 reinforces Texas’ reputation as a leader in business innovation and practical policymaking”, said the Council. …
Texas Bill to Ban Hemp-Derived THC Vetoed by Governor Abbott
Texas Governor Greg Abbott has vetoed legislation that would have outlawed most hemp-derived THC products, including popular items like delta-8 and THCA, which are widely sold in smoke shops, wellness stores, and online. The proposal, Senate Bill 3, would have prohibited the sale of hemp-based THC products intended for ingestion, inhalation, or topical use, effectively …
The 50 Most Impactful Cannabis Studies Published in the First Half of 2025
In the first half of 2025, researchers around the world have published a wave of peer-reviewed studies examining the effects of cannabis and its various compounds on dozens of health conditions. Scientists have looked at CBD, THC, CBG, THCV, and other cannabis components in studies related to cancer, chronic pain, epilepsy, anxiety, gut health, and …
Anchorage Cannabis Sales Top $25 Million in First Three Months of 2025
According to data released by city officials, Anchorage’s legal cannabis market generated over $25 million in sales between January 1 and March 31 of this year. The data from the Anchorage Finance Department’s Treasury Division shows that in the first three months of 2025, licensed outlets sold $25,655,639 worth of cannabis and cannabis products, resulting …
CBD Treatment Associated With Seizure Reduction in Rett Syndrome and CDKL5 Deficiency, Study Finds
In a new study conducted by researchers from 19 universities and research hospitals in Italy, highly purified CBD reduced seizures in two-thirds of patients with Rett Syndrome (RTT) or CDKL5 Deficiency Disorder (CDD), two rare genetic conditions often marked by severe drug-resistant epilepsy. Published in the journal Epilepsia Open, the study involved 27 patients—26 of them female—with …
Texas Governor Signs Bill Expanding State’s Medical Marijuana Program
Texas Governor Greg Abbott has signed legislation expanding the state’s limited medical marijuana program, broadening access for patients and increasing the number of licensed dispensaries. House Bill 46, approved with strong bipartisan support, adds several new qualifying conditions to the state’s compassionate use program, including chronic pain, terminal illness, and traumatic brain injury. Until now, …
Rhode Island Legislature Approves Resolution Directing Cannabis Commission to Draft Rules for Hemp THC Beverages
The Rhode Island Senate on Friday gave approval to a resolution calling on the state’s Cannabis Control Commission to develop recommendations for regulating and licensing intoxicating hemp-derived beverages. The move comes just three days after the measure passed the House, and the resolution will soon be transmitted to Governor Dan McKee. The joint resolution, introduced …
Study: Lipid-Based CBD Nanoemulsion May Reduce Anxiety and Panic Symptoms
A new study published in the journal Brain Research provides evidence that chronic use of a lipid-based cannabidiol (CBD) nanoemulsion may help reduce anxiety and panic-like behavior by targeting brain areas involved in emotional regulation. Conducted by researchers from the Universidade Federal do Ceará and Universidade Federal de São Paulo in Brazil, the study evaluated …
Sponsored
